Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E Congly

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Annals of Hepatology|March 26, 2022
Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?Stephen E Congly
Hepatobiliary Surgery and Nutrition|April 15, 2024
Quality standards on management of alcohol-related liver disease from the UK-targets and tribulationsBryce Tkachuk, Stephen E Congly
Annals of Hepatology|September 12, 2025
Reply to Suoh et alStephen E Congly, Leah Yao
CMAJ Open|March 31, 2019
Variable access to antiviral treatment of chronic hepatitis B in Canada: a descriptive studyStephen E Congly, Mayur Brahmania
Alimentary Pharmacology & Therapeutics|June 23, 2023
Editorial: Alcohol-related liver disease is the primary driver of cirrhosis-related hospital admissions in the COVID-19 era-What can be done?Alexandra D Frolkis, Stephen E Congly
Transplantation|September 7, 2019
Distinguishing Between Sex and Gender Is Critical for Research in TransplantationStephen E Congly, Kristi A Brownfield
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 8, 2013
Liver transplantation for alcoholic liver disease: a devilish dilemmaStephen E Congly, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2012
Prediction of bleeding etiology: the clinician is vindicated!Stephen E Congly, Alexander I Aspinall
The American Journal of Gastroenterology|April 5, 2014
Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remainStephen E Congly, Michael D Leise
Current Gastroenterology Reports|January 15, 2013
Portal vein thrombosis: should anticoagulation be used?Stephen E Congly, Samuel S Lee
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Annals of Hepatology|March 26, 2022
Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?Stephen E Congly
Hepatobiliary Surgery and Nutrition|April 15, 2024
Quality standards on management of alcohol-related liver disease from the UK-targets and tribulationsBryce Tkachuk, Stephen E Congly
Annals of Hepatology|September 12, 2025
Reply to Suoh et alStephen E Congly, Leah Yao
CMAJ Open|March 31, 2019
Variable access to antiviral treatment of chronic hepatitis B in Canada: a descriptive studyStephen E Congly, Mayur Brahmania
Alimentary Pharmacology & Therapeutics|June 23, 2023
Editorial: Alcohol-related liver disease is the primary driver of cirrhosis-related hospital admissions in the COVID-19 era-What can be done?Alexandra D Frolkis, Stephen E Congly
Transplantation|September 7, 2019
Distinguishing Between Sex and Gender Is Critical for Research in TransplantationStephen E Congly, Kristi A Brownfield
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 8, 2013
Liver transplantation for alcoholic liver disease: a devilish dilemmaStephen E Congly, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2012
Prediction of bleeding etiology: the clinician is vindicated!Stephen E Congly, Alexander I Aspinall
The American Journal of Gastroenterology|April 5, 2014
Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remainStephen E Congly, Michael D Leise
Current Gastroenterology Reports|January 15, 2013
Portal vein thrombosis: should anticoagulation be used?Stephen E Congly, Samuel S Lee
Pageof 8